Member Info for doggo

Longlad

It would pay you to read the RNS from last week. If you can’t manage the few paragraphs to find out then just read the heading.

Don’t listen to the dissenting voices on here this morning...

Let’s wait and see if the market likes what they hear.

“This is a significant milestone for the cannabis sector in the UK as well as for EMMAC, as Europe’s leading medical cannabis company.”

Emmac own the UK’s first and only operational distance medical cannabis pharmacy. What the government did yesterday was to change import restrictions on medicinal cannabis products, which will provide faster access to cannabis-based products for medicinal use resulting in UK patients not have their treatment delayed or interrupted.

Longlad etc won’t be on tonight.

They don’t comment on really significant PF news.

7 am

Again if you’ve sold tough

https://www.emmac.com/response-to-government-granting-faster-access-to-cannabis-based-medicines/

Unique

https://twitter.com/greenhamneggs/status/1234528831140237313?s=21

Here’s a direct quote from the mouth of Greg Bailey CEO JUVENESCENCE

“We just signed a deal to try and prevent Alzheimer’s and Parkinson’s.”

Sucks for those 6p sellers. Shame on you. Lol

Stock div yes
Cash div no

There’s around 5 of them

I like the one who makes the same spelling errors consistently. They are generally tired and hubby has been to see the specialists again and they are awfully tired blah blah cry cry

You really are the most stupid pair ever to write on this board.

irony of you writing the following “Will those who you advice to sell be after your skin when FFWD shoots up, or will they thank you for saving them money by getting out now if FFWD collapses.
We all write to much on here just for the sake of writing.”

You’ve never written a sentence of any substance since your crew joined this board.

Reverse Psychology?
Anyone trading out at current SP with the impending news stacked against them must have balls of steel.

Wouldn’t worry about the difference between SP & NAV. The Leap investment 43.9% should be compared with GAN. The customer & partner base of Leap outweighs GAN’s and as such Leap alone far exceeds the total MCAP of FFWD as will be evidenced with their IPO valuation.

My advice? I’d keep selling

Does LSE pick & choose what trades to show?

NEWS RELEASE 26-FEB-2020
AI preclinical research program targeting brain cancers starts at Insilico Medicine
New AI-powered discovery generative biology and generative chemistry effort targeting brain tumors with the focus on GBM launches at Insilico Medicine

GBM is the most severe and aggressive form of brain cancer in adults with a life expectancy of less than 3 years for the recurrent form of the disease. Globally, GBM affects 150,000 patients annually, with the annual growth rate expected to increase. In the US alone, 16,000 new cases are reported annually.

Zhavoronkov, PhD CEO/Co-founder of Insilico Medicine commented on the start of the brain cancer project, 'Brain cancers are the worst diseases anyone can ever get and the most rare cancers are often overlooked because the efforts are expensive, the market is small, and the probability of failure is high. We will try to change this with our AI-powered drug discovery pipeline. We needed to have a seasoned big pharma veteran to drive this process to the point where it can be quickly developed and externalized.

In the short-term, we will see companies progress through their seed and Series A-D rounds, after which some will go public with IPOs. Juvenescence announced recently that they would shortly be initiating their crossover round, with the intention of going public (on NASDAQ) in the second half of 2020. Mellon predicts that a proliferation of longevity-focused funds will form in the next few years, foreseeing that the current 10 or so longevity-focused funds will multiply into the thousands within a decade.

Wednesday treat or Wednesday tears

I’ll post something nice at 431

I would watch the Ed Mac interview again. Deramp all you wish. Big buyers along shortly to take up all the cut price deals you create.